[May 08, 2014] |
|
Research and Markets: Rectal Cancer - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/34rnw9/rectal_cancer)
has announced the addition of the "Rectal
Cancer - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Rectal Cancer, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Rectal
Cancer and special features on late-stage and discontinued projects.
Scope
-
The report prvides a snapshot of the global therapeutic landscape of
Rectal Cancer
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Rectal Cancer and enlists all their major and minor
projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Rectal Cancer products under development by companies
and universities/research institutes based on information derived from
company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Rectal Cancer pipeline on the basis of target, MoA,
route of administration and molecule type
-
Latest news and deals relating related to pipeline products
Companies Mentioned:
-
AbbVie Inc.
-
Celltrion, Inc.
-
Eisai Co., Ltd.
-
GenVec, Inc.
-
GlaxoSmithKline plc
-
Hanwha Chemical Corporation
-
Isofol Medical AB
-
Merck & Co., Inc.
-
Merck KGaA
-
Nanobiotix
-
Peregrine Pharmaceuticals, Inc.
-
Synta Pharmaceuticals Corp.
For more information visit http://www.researchandmarkets.com/research/34rnw9/rectal_cancer
[ Back To TMCnet.com's Homepage ]
|